Complex Chemistry for Antibody-Drug Conjugates and Beyond

The development of antibody-drug conjugates (ADCs) and other bioconjugates requires highly specialized chemistry, including the design and synthesis of complex molecules such as cytotoxins and other linker payloads.

At Abzena, we excel in complex chemistry, providing end-to-end support for the entire ADC lifecycle from discovery and design to development and clinical manufacturing.

Our complex chemistry expertise drives the rapid development and manufacture of highly potent compounds, linker payloads, and bioconjugates. Our innovative strategies, process development expertise and scalable manufacturing ensures that your ADC program progresses confidently from discovery to clinical and commercial stages.

Whether developing novel payloads or optimizing existing routes, our integrated approach guarantees quality, efficiency, and success.

Download our ‘Complex Chemistry for Antibody-Drug Conjugates and Beyond’ info sheet today to discover how our expert chemistry team, technologies and strategies can move your ADC development program forward.

Download Info Sheet

You May Also be Interested in